Ph.D. Debkishore Mitra - 01 Mar 2022 Form 4 Insider Report for Lucira Health, Inc.

Role
Chief Technology Officer, Director
Signature
/s/ Dan George, Attorney-in-Fact for Debkishore Mitra, Ph.D.
Issuer symbol
N/A
Transactions as of
01 Mar 2022
Net transactions value
-$4,509
Form type
4
Filing time
12 Jul 2022, 18:27:34 UTC
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Sale $4,165 -890 -0.23% $4.68* 382,585 01 Mar 2022 Direct F1, F2
transaction LHDXQ Common Stock Sale $344 -186 -0.05% $1.85* 382,399 01 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 10, 2021 for 8,250 shares.
F2 Includes 1,470 shares and 2,552 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on August 20, 2021 and February 20, 2022, respectively.